CN102657720A - Traditional Chinese medicine for treating diabetic dyslipidemia - Google Patents

Traditional Chinese medicine for treating diabetic dyslipidemia Download PDF

Info

Publication number
CN102657720A
CN102657720A CN2012101853144A CN201210185314A CN102657720A CN 102657720 A CN102657720 A CN 102657720A CN 2012101853144 A CN2012101853144 A CN 2012101853144A CN 201210185314 A CN201210185314 A CN 201210185314A CN 102657720 A CN102657720 A CN 102657720A
Authority
CN
China
Prior art keywords
chinese medicine
radix
extract
diabetic dyslipidemia
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012101853144A
Other languages
Chinese (zh)
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lvyuan Qiuzheng Technology Development Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2012101853144A priority Critical patent/CN102657720A/en
Publication of CN102657720A publication Critical patent/CN102657720A/en
Pending legal-status Critical Current

Links

Abstract

The invention relates to a traditional Chinese medicine for treating diabetic dyslipidemia, and belongs to the field of traditional Chinese medicines for treating diabetes, and the traditional Chinese medicine for treating diabetic dyslipidemia is good in effect and quick in effect taking. The traditional Chinese medicine is prepared from the raw materials such as adenophora stricta, hawthorn, salvia miltiorrhiza, ganoderma lucidum and tienchi ginseng, has the effects of supporting body resistance, reinforcing qi and nourishing blood, promoting blood circulation to remove blood stasis, and lowering lipid, and has the advantages of being good in effect and quick in effect taking.

Description

A kind of Chinese medicine of treating the diabetic dyslipidemia
Technical field
The invention belongs to the field of Chinese medicines of treatment diabetes.
Background technology
In the diabetics,, be referred to as the diabetic dyslipidemia because the biological regulating action generation obstacle of insulin often with the disorder of lipid metabolism, abnormalities of sugar/lipid metabolism occurs.Be often referred in the blood plasma cholesterol with (or) triglyceride increases unusually.These unusual lipidosiss that raise form AP on blood vessel wall, cause vascular wall narrow even inaccessible, cause angina pectoris, myocardial infarction, the cerebral infarction serious consequence of waiting indefinitely, life threatening.According to statistics, have in the diabetics or people's blood fat increase unusually, commonplace.Be used to treat the Chinese medicine of diabetic dyslipidemia at present; Exist some significantly not enough: the one, effect is obvious inadequately; The 2nd, it is slower to take effect; A large amount of patients since the treatment that can not get active drug all the year round dyslipidemia increase, triglyceride, T-CHOL etc. are high in the blood, are faced with the danger that arteriosclerosis increases the weight of, suffers from hypertension, coronary heart disease constantly.Patient and family members are very dissatisfied to this.
To problem set forth above, the present invention provides a kind of Chinese medicine of treating the diabetic dyslipidemia, and it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect; The slower problem that takes effect, effective, instant effect, it is remarkable to have effect; Drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention realizes through following technical scheme:
1, a kind of Chinese medicine of treating the diabetic dyslipidemia adopts the raw material of Chinese medicine preparation, and prescription is by weight being:
Radix Adenophorae (Radix Glehniae) 4---10 parts of 7 portions of Fructus Crataegis 6---10 parts of Radix Salviae Miltiorrhizaes 6---
9 parts of Ganodermas 6---10 portions of Radix Notoginseng 5---
The Chinese medicine of this treatment diabetic dyslipidemia is processed by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is following: Ganoderma is broken into graininess, crosses 40 mesh sieves Hot water (95 ℃) lixiviate with 1:20 Lixiviating solution decompression, concentrated 95% ethanol with 3 times of volumes mixes, left standstill 10-12 hours, centrifugal Add 75% ethanol, the deposition polysaccharide Dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng is extracted with the alcoholysis water extraction, method is; With Notoginseng Root with 1.6 times of 70% alcohol desorption after; With 20 times of water level volumes 45 ℃ and-P boiling extraction in reducing pressure under the 0.084MPa, extract 4min/ time 2 times; Extracting solution directly adopts macroporous resin to carry out adsorbing separation and gets extract Radix Notoginseng total arasaponins fine powder after concentrating;
(3) by above-mentioned weight ratio, Radix Adenophorae (Radix Glehniae), Fructus Crataegi, Radix Salviae Miltiorrhizae are extracted through conventional water extraction process, process the extract fine powder, mix, stir, process Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.We think that the pathogenesis that the diabetic dyslipidemia increases mainly belongs to " void ", " heat " and " stasis of blood " at research.The most hypoimmunities of diabetics are given birth in the deficiency-heat, and the bright body fluid of consumption causes two problems for blood and blood vessel: the one, and lipid (cholesterol, triglyceride) row unnecessary in the blood does not go out, and is detained in the blood, promotes the rising of blood stickiness; The 2nd, low density cholesterol (bad cholesterol) concentration raises in the blood, is deposited on the blood vessel wall, has quickened sclerosis of blood vessels, and can clear up high density cholesterol (good cholesterol) lowering of concentration of fat speckle on the blood vessel wall, thereby formed the unusual of blood fat.In view of the above, the present invention gives prominence to and sets upright, enhancing human body immunity power, sets upright reinforcement with blood circulation promoting and blood stasis dispelling organically to combine, and obtains remarkable result.Among the we, the Ganoderma the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood, the tonification the five internal organs, enhancing human body immunity power, " removing " effect of immunity is a key factor of removing unnecessary lipid, high density lipoprotein increasing, reduction low density lipoprotein, LDL in the blood; 5 with Radix Salviae Miltiorrhizae, Radix Notoginseng, Fructus Crataegi, and three flavors all are blood circulation promoting and blood stasis dispelling medicines, and " Radix Salviae Miltiorrhizae simply, merit is with four things ", Radix Salviae Miltiorrhizae can passage, nourishing bloods, again can blood circulation promoting and blood stasis dispelling, and simultaneously, Radix Salviae Miltiorrhizae calm the nerves relieving restlessness and removing heat from blood have the merit of YIN nourishing and the production of body fluid promoting; The Radix Notoginseng blood stasis dispelling analgesic therapy of invigorating blood circulation can just not hindered again in blood stasis dispelling, and Zhang Xichun is referred to as " blood stasis dispelling blood and do not hinder fresh blood, fair be treating blood disorders quality goods "; The circulation of qi promoting of Fructus Crataegi dissipating blood stasis, modern pharmacological research, Fructus Crataegi fluid extract can make the laboratory animal blood fat obviously reduce, and the merit that three distinguish the flavor of share the dissipating blood stasis blood stasis dispelling is more outstanding; Assistant is cold in nature with Radix Adenophorae (Radix Glehniae), and replenishing YIN and removing heat is to separate the heat of quenching one's thirst.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, the merit of blood circulation promoting and blood stasis dispelling blood fat reducing, have effective, the advantage of instant effect.
The specific embodiment
Through following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Radix Adenophorae (Radix Glehniae) 400 Keshan short, bristly hair or beards 600 gram Radix Salviae Miltiorrhizaes 600 grams
Ganoderma 600 gram Radix Notoginseng 500 grams
Press predetermined weight, Ganoderma is extracted with the method for content of the present invention (1); Method with content of the present invention (2) is extracted Radix Notoginseng; With conventional water extraction process Radix Adenophorae (Radix Glehniae), Fructus Crataegi, Radix Salviae Miltiorrhizae are extracted, process extract fine powder 270 grams altogether, above-mentioned three kinds of extract fine powders are mixed; Stir, process fine particle, the capsule of packing into No. 0; Process 900 of Chinese medicinal capsules, every capsules includes Chinese medicine extract 0.3 gram.
2, get following prescription (weight is unit by gram):
Radix Adenophorae (Radix Glehniae) 700 Keshan short, bristly hair or beards 1000 gram Radix Salviae Miltiorrhizaes 1000 grams
Ganoderma 1000 gram Radix Notoginseng 900 grams
By above-mentioned same method, process 1533 of Chinese medicinal capsules, every capsules includes Chinese medicine extract 0.3 gram.
3, get following prescription (by weight):
7 parts of 7 parts of Radix Salviae Miltiorrhizaes of 5 portions of Fructus Crataegis of Radix Adenophorae (Radix Glehniae)
6 parts of 7 portions of Radix Notoginseng of Ganoderma
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine extract 0.3 gram.
4, get following prescription (by weight):
9 parts of 9 parts of Radix Salviae Miltiorrhizaes of 6 portions of Fructus Crataegis of Radix Adenophorae (Radix Glehniae)
8 parts of 9 portions of Radix Notoginseng of Ganoderma
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine extract 0.3 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science diabetic dyslipidemia, through 17 routine clinical observations.Select tcm diagnosis diabetic dyslipidemia to increase and be standard: diabetics serum inspection on an empty stomach has hyperlipemia---total triglyceride>and 150mg/dl (normal value 70---150), T-CHOL>200 mg/dl (normal value 129---179), HDL-C≤35 mg/dl (normal value 23---67), low-density lipoprotein cholesterol>=160 mg/dl; As above index can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 8 examples, women's 9 examples do not have other serious disease, and the age is 41 years old-75 years old, 59.7 years old mean age.
Efficacy determination:
1, produce effects: reach following each person: T-CHOL fall >=20%, triglyceride fall >=40%, HDL-C ascending amount >=0.26mmoI/L.
2, effective: the T-CHOL fall is not less than 10%, and the triglyceride fall is not less than 20%, HDL-C ascending amount 0.104.
3, invalid: as not reach effective standard.
During clinical experiment, withdraw other medicines and health nutrient.Taking the Chinese medicinal capsule that embodiment of the present invention 1 is made, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine extract 0.3 gram, warm water delivery service after meal, index promptly has alleviation after 1 month, take 3 months after, index is obviously improved.17 philtrums of clinical experiment, produce effects 7 people, effective 8 people, invalid 2 people, total effective rate 88.2%.

Claims (1)

1. Chinese medicine of treating the diabetic dyslipidemia is characterized in that: said Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Radix Adenophorae (Radix Glehniae) 4---10 parts of 7 portions of Fructus Crataegis 6---10 parts of Radix Salviae Miltiorrhizaes 6---
9 parts of Ganodermas 6---10 portions of Radix Notoginseng 5---
The Chinese medicine of this treatment diabetic dyslipidemia is processed by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is following: Ganoderma is broken into graininess, crosses 40 mesh sieves Hot water (95 ℃) lixiviate with 1:20 Lixiviating solution decompression, concentrated 95% ethanol with 3 times of volumes mixes, left standstill 10-12 hours, centrifugal Add 75% ethanol, the deposition polysaccharide Dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng is extracted with the alcoholysis water extraction, method is; With Notoginseng Root with 1.6 times of 70% alcohol desorption after; With 20 times of water level volumes 45 ℃ and-P boiling extraction in reducing pressure under the 0.084MPa, extract 4min/ time 2 times; Extracting solution directly adopts macroporous resin to carry out adsorbing separation and gets extract Radix Notoginseng total arasaponins fine powder after concentrating;
(3) by above-mentioned weight ratio, Radix Adenophorae (Radix Glehniae), Fructus Crataegi, Radix Salviae Miltiorrhizae are extracted through conventional water extraction process, process the extract fine powder, mix, stir, process Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
CN2012101853144A 2012-06-07 2012-06-07 Traditional Chinese medicine for treating diabetic dyslipidemia Pending CN102657720A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012101853144A CN102657720A (en) 2012-06-07 2012-06-07 Traditional Chinese medicine for treating diabetic dyslipidemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012101853144A CN102657720A (en) 2012-06-07 2012-06-07 Traditional Chinese medicine for treating diabetic dyslipidemia

Publications (1)

Publication Number Publication Date
CN102657720A true CN102657720A (en) 2012-09-12

Family

ID=46767388

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012101853144A Pending CN102657720A (en) 2012-06-07 2012-06-07 Traditional Chinese medicine for treating diabetic dyslipidemia

Country Status (1)

Country Link
CN (1) CN102657720A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916555A (en) * 1996-11-01 1999-06-29 Sam Chun Dang Pharm Co., Ltd. Pharmaceutical composition for treatment of diabetes
CN1602740A (en) * 2004-11-12 2005-04-06 张玉祖 Healthcare tablet for reducing blood fat and benefiting health
KR20100072709A (en) * 2008-12-22 2010-07-01 정산생명공학 주식회사 Composition for preventing and treating diabetics by hyperglycemic action
CN101991647A (en) * 2010-11-04 2011-03-30 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating diabetic coronary heart diseases
KR20120021864A (en) * 2010-08-19 2012-03-09 주식회사 면역과학연구소 Antidiabetic composition comprising plants extract mixture
CN102379911A (en) * 2011-07-23 2012-03-21 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating cancer pain

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916555A (en) * 1996-11-01 1999-06-29 Sam Chun Dang Pharm Co., Ltd. Pharmaceutical composition for treatment of diabetes
CN1602740A (en) * 2004-11-12 2005-04-06 张玉祖 Healthcare tablet for reducing blood fat and benefiting health
KR20100072709A (en) * 2008-12-22 2010-07-01 정산생명공학 주식회사 Composition for preventing and treating diabetics by hyperglycemic action
KR20120021864A (en) * 2010-08-19 2012-03-09 주식회사 면역과학연구소 Antidiabetic composition comprising plants extract mixture
CN101991647A (en) * 2010-11-04 2011-03-30 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating diabetic coronary heart diseases
CN102379911A (en) * 2011-07-23 2012-03-21 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating cancer pain

Similar Documents

Publication Publication Date Title
CN103169793B (en) Medicine for treating hypertension, hyperlipoidemia and diabetes mellitus
CN102579836B (en) Traditional Chinese medical dendrobium huoshanense composition and preparation method thereof
CN102379990A (en) Traditional Chinese medicine for treating cancer ache
CN102114074A (en) Traditional Chinese medicine for treating diabetic diarrhea
CN102139049A (en) Traditional Chinese medicine for treating diabetic skin pruritus
CN101254280B (en) Coronary circulation promoting, intelligence benefiting Chinese medicine for curing vascular dementia
CN102614271A (en) Chinese medicine for treating diabetic dyslipidemia
CN106389818A (en) Traditional Chinese medicine composition for treating insomnia and preparation method thereof
CN102319382A (en) Chinese medicine for treating carcinomatous pains
CN106361976A (en) Compound preparation for calming nerves, promoting sleep and keeping beauty and preparation method of compound preparation
CN101953892A (en) Traditional Chinese medicine for treating diabetic cutaneous pruritus
CN102114077A (en) Traditional Chinese medicine for treating diabetic skin pruritus
CN101961420A (en) Traditional Chinese medicine for treating diabetic nephropathy
CN102068515A (en) Traditional Chinese medicine for treatment of diabetic diarrhea
CN102657720A (en) Traditional Chinese medicine for treating diabetic dyslipidemia
CN102172378A (en) Traditional Chinese medicine for treating diabetic coronary heart disease
CN102091176A (en) Traditional Chinese medicine for treating diabetic diarrhoea
CN101961387A (en) Traditional Chinese medicine for treating diabetic skin pruritus
CN102657774A (en) Traditional Chinese medicine for treating diabetic hypertension
CN105030917A (en) Compound preparation for treating alcoholic fatty liver
CN101991648A (en) Traditional Chinese medicine for treating diabetic coronary heart disease
CN102091229A (en) Traditional Chinese medicine for treating diabetic coronary heart disease
CN101991647A (en) Traditional Chinese medicine for treating diabetic coronary heart diseases
CN101987175A (en) Traditional Chinese medicine for treating diabetic gastroplegia
CN101961421A (en) Traditional Chinese medicine for treating diabetic nephropathy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120912